Molecular Partners AG
MOLN
$3.77
-$0.20-5.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 32.56% | -13.71% | -28.76% | 42.02% | -72.48% |
| Total Depreciation and Amortization | -35.17% | 2.47% | -3.64% | 97.66% | -48.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -218.97% | 732.08% | 110.47% | -180.98% | 546.22% |
| Change in Net Operating Assets | 320.39% | 67.25% | 43.93% | -132.41% | 11.17% |
| Cash from Operations | 2.15% | 11.68% | 10.84% | -7.99% | -20.89% |
| Capital Expenditure | 47.86% | -41.41% | -50.61% | 58.54% | -222.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -129.65% | 13.47% | -27.27% | -9.10% | 10.30% |
| Cash from Investing | -131.13% | 13.06% | -27.81% | -8.34% | 9.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.33% | 0.00% | -0.33% | -0.33% | 0.00% |
| Issuance of Common Stock | 1,734,400.00% | -97.14% | 3,400.00% | -50.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,106.78% | -17.85% | 13.93% | -1.96% | 0.27% |
| Foreign Exchange rate Adjustments | 187.96% | -429.77% | -77.38% | 118.39% | -587.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,902.75% | 102.59% | -348.16% | 196.26% | -121.09% |